VMCPX
Price
$398.34
Change
+$1.00 (+0.25%)
Updated
Oct 3 closing price
Net Assets
199.16B
VMIDX
Price
$25.70
Change
+$0.08 (+0.31%)
Updated
Oct 3 closing price
Net Assets
N/A
Interact to see
Advertisement

VMCPX vs VMIDX

Header iconVMCPX vs VMIDX Comparison
Open Charts VMCPX vs VMIDXBanner chart's image
Vanguard Mid Cap Index InstitutionalPlus
Price$398.34
Change+$1.00 (+0.25%)
VolumeN/A
Net Assets199.16B
VALIC Company I Mid Cap Index
Price$25.70
Change+$0.08 (+0.31%)
VolumeN/A
Net AssetsN/A
VMCPX vs VMIDX Comparison Chart in %
View a ticker or compare two or three
VS
VMCPX vs. VMIDX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VMCPX is a Hold and VMIDX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCPX pays higher dividends than VMIDX: VMCPX (1.50) vs VMIDX (1.22). VMCPX was incepted earlier than VMIDX: VMCPX (15 years) vs VMIDX (34 years). VMIDX (0.36) is less costly to investors than VMCPX (0.03). VMIDX is a more actively managed with annual turnover of: 21.00 vs. VMCPX (16.00). VMIDX has a lower initial minimum investment than VMCPX: VMIDX (0) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 13.03 vs. VMIDX (-5.38). VMCPX return over 5 years is better than : 67.54 vs. VMIDX (21.62).
VMCPXVMIDXVMCPX / VMIDX
Total Expense Ratio0.030.359%
Annual Report Gross Expense Ratio0.030.368%
Fund Existence15 years34 years-
Gain YTD11.963-6.606-181%
Front LoadN/AN/A-
Min. Initial Investment1000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets199BN/A-
Annual Yield % from dividends1.501.22122%
Returns for 1 year13.03-5.38-242%
Returns for 3 years48.137.65629%
Returns for 5 years67.5421.62312%
Returns for 10 years151.3210.701,415%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ERAS2.420.29
+13.62%
Erasca
BRTX1.500.07
+4.90%
BioRestorative Therapies
NCNO26.230.35
+1.35%
nCino
DVN34.560.24
+0.70%
Devon Energy Corp
MOLN3.71N/A
+0.02%
Molecular Partners AG